Wall Street analyst price targets, ratings consensus & upside potential · Updated Feb 28, 2026
Last 12 months price action with 12-month analyst target path
As of February 28, 2026, Johnson & Johnson (JNJ) has a Wall Street consensus price target of $229.33, based on estimates from 39 covering analysts. With the stock currently trading at $248.43, this represents a potential downside of -7.7%. The company has a market capitalization of $598.69B.
Analyst price targets range from a low of $190.00 to a high of $265.00, representing a 33% spread in expectations. The median target of $220.00 aligns closely with the consensus average.
The current analyst consensus rating is Buy, with 20 analysts rating the stock as a Buy or Strong Buy,16 rating it Hold, and 3 rating it Sell or Strong Sell. The positive sentiment balance indicates moderate optimism about the stock prospects.
From a valuation perspective, JNJ trades at a trailing P/E of 42.9x and forward P/E of 21.5x. The forward PEG ratio of 38.22 reflects a premium valuation. Analysts expect EPS to grow +11.8% over the next year.
Our proprietary valuation model, which blends historical multiples with forward estimates, suggests a base-case price target of $533.34, with bear and bull scenarios of $354.39 and $612.16 respectively. Model confidence stands at 64/100, reflecting moderate uncertainty in projections.
Price is only half the story. See total return with reinvested dividends.
Launch CalculatorSee our Bear / Base / Bull DCF models and intrinsic value estimates.
View ValuationSee how JNJ stacks up against sector leader Agios Pharmaceuticals, Inc..
Start ComparisonWall Street's consensus price target for JNJ is $229.33, -7.7% from its current price of $248.43. The below-market target from 39 analysts suggests limited near-term appreciation.
JNJ has a consensus rating of "Buy" based on 39 Wall Street analysts. The rating breakdown is predominantly bullish, with 20 Buy/Strong Buy ratings. The consensus 12-month price target of $229.33 implies -7.7% downside from current levels.
JNJ trades at a forward P/E of 21.4808x, representing a moderate valuation. With analysts targeting $229.33 (-7.7% implied move), the stock appears close to fair value.
The most bullish Wall Street analyst has a price target of $265 for JNJ, while the most conservative target is $190. The consensus of $229.33 represents the median expectation. Our quantitative valuation model projects a bull case target of $612 based on optimistic growth and margin assumptions. These targets typically reflect 12-month expectations.
JNJ is heavily covered by Wall Street, with 39 analysts providing price targets and ratings. Of these, 0 have Strong Buy ratings, 20 have Buy ratings, 16 recommend Hold, and 3 have Sell or Strong Sell ratings. Higher analyst coverage generally indicates greater institutional interest and more reliable consensus estimates.
The 12-month JNJ stock forecast based on 39 Wall Street analysts shows a consensus price target of $229.33, with estimates ranging from $190 (bear case) to $265 (bull case). The median consensus rating is "Buy". Our proprietary valuation model produces a base case fair value of $533, with bear/bull scenarios of $354/$612.
Our quantitative valuation model calculates JNJ's fair value at $533 (base case), with a bear case of $354 and bull case of $612. The model uses discounted cash flow analysis, historical growth rates, and margin mean-reversion to project FY+2 earnings, then applies an appropriate P/E multiple. The model confidence score is 64/100.
JNJ trades at a forward P/E ratio of 21.5x based on next-twelve-months earnings estimates compared to a trailing P/E of 42.9x. The lower forward P/E indicates analysts expect earnings growth. A forward P/E is useful for comparing valuations when earnings are expected to change significantly.
Analysts are cautious on JNJ, with 3 Sell ratings and a price target of $229.33 (-7.7% from current price). The "Buy" consensus suggests careful evaluation before buying. This information is for educational purposes only. Always conduct your own research, consider your financial situation, and consult a financial advisor before making investment decisions.
JNJ analyst price targets range from $190 to $265, a 33% moderate spread showing some variance in outlooks. Differences stem from varying assumptions about revenue growth, profit margins, competitive dynamics, and valuation multiples. The $229.33 consensus represents the middle ground. Our model's $354-$612 range provides an independent fundamental perspective.